Navigation Links
Hypertension in Medical Technology

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... worsening in patients with pulmonary arterial hypertension (PAH)(1). The randomized, double-blind, 16-week, ... University of Bologna and head of the Pulmonary hypertension Centre at the Institute of Cardiology. "The ... promote and commercialize ADCIRCA for pulmonary hypertension in the United States and Puerto Rico from Eli ...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... were presented today at the American Society of hypertension (ASH) Twenty-Fourth Annual Scientific Meeting and ... controlled. The prevalence of Stage 1 and Stage 2 hypertension decreased from 32 to 11 percent and from 9 to 2 ... for an average of five years. Patients with hypertension were also treated at the investigator's ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... found that both the prevalence and severity of hypertension increase as people get older, making it critical ... risk of adverse events, the findings show hypertension treatment can be accomplished safely and ... create serious problems elsewhere in the body.(4) hypertension is one of the most prevalent conditions in the ...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

... 24-hour ambulatory BP reductions in patients with hypertension from two groups with elevated risk for developing ... regimen can be an effective tool for treating hypertension in more challenging patient populations, such as ... create serious problems elsewhere in the body.(4) hypertension is one of the most prevalent conditions in the ...

NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study

... of a second large ABPM study in patients with hypertension and OA (112) before the end of 2008, in addition ... design, in which 118 OA patients with controlled hypertension were enrolled at 30 clinical sites in the ... patients were diagnosed with controlled essential hypertension (i.e. SBP <140 mmHg and DBP <90 mmHg) and were ...

Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds

... "The inevitable downhill sequence to hypertension and heart failure was changed by the addition of ... that we think are having an effect against the hypertension may be the flavanoids - either by ... grapes, can do in this particular model of hypertension and heart failure, we would not directly tell ...

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

... in patients with pulmonary arterial hypertension (PAH) -- Current treatment options have ... in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel ... Ardeschir Ghofrani, MD, Head of Pulmonary hypertension Division, University Hospital Giessen und ...

Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease

... that, in mildly symptomatic pulmonary arterial hypertension (PAH) patients (WHO functional class II - WHO FC ... Notes to editor About Pulmonary Arterial hypertension (PAH) PAH is a syndrome characterized by a ... are defined as patients with pulmonary hypertension resulting in mild limitation of physical ...

Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies

... will be presented at the European Society of hypertension meeting (ESH) in Berlin beginning June 14, ... Exchange: INCR) is disrupting the $42 billion hypertension industry with the world's first FDA-cleared, OTC ... RESPeRATE has gained widespread support of hypertension specialists and has secured regulatory clearance ...

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

... in the Journal of the American Society of hypertension demonstrate that early blockade of angiotensin ... in the current Journal of the American Society of hypertension demonstrates that the hypertension treatment olmesartan medoxomil was effective in ...

New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk

... anti-hypertensive drug therapy for stage one hypertension whereas life-style changes only are guided in the ... for the diagnosis and management of hypertension are based solely on brachial pressure, yet this ... issue of the American Heart Association's journal hypertension in a study titled "Central Pressure: Variability ...

Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations

... study conducted in 1,940 pts with mild to severe hypertension (SeDBP)(*) 95-120 mm Hg) to determine if ... (those with diabetes).(4) "As we know, hypertension affects many people from all walks of life," said ... because it often has no specific symptoms, hypertension increases the risk of cardiovascular and related ...

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

... percent (45%) of patients with stage 1 hypertension treated with a regimen of BENICAR(R) (olmesartan ... out of 10 (cumulative 81%) patients with stage 1 hypertension were able to reach a goal blood pressure (BP) of ... of 10 (cumulative 60.3%) patients with stage 1 hypertension were able to achieve a BP of ...

Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society

... for the treatment of pulmonary arterial hypertension will be presented at the annual meeting of ... EDT. Lewis Rubin, MD, Director of the Pulmonary hypertension Program at the University of California San ... McLaughlin, MD, Director of the Pulmonary hypertension Program at the University of Michigan, ...

Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil

... in a study population of patients with portal hypertension resulting from liver disease. Udenafil ... in the growing and underserved portal hypertension market which is projected to be 6 million people (US, EU and Japan) by 2010. Portal hypertension is the build-up of pressure in the portal vein ...

Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development

... Ongoing Phase 2a hypertension Study PRINCETON, N.J., Feb. 11 ... clinical pipeline consists of PS433540 (DARA) for hypertension and diabetic nephropathy and PS178990 (SARM) for ... trial in subjects with Stage I and Stage II hypertension is progressing well. The trial remains on ...

High Blood Pressure May Heighten Effects of Alzheimer's Disease

... Society of North America (RSNA). "While hypertension is not a cause of Alzheimer's disease, our ... of Pittsburgh where the study was conducted. hypertension is a condition in which the blood circulates ... million Americans have hypertension. People with hypertension are at elevated risk for heart attack, stroke ...

Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood

... seven-week trial, patients with severe hypertension (mean baseline 172/113 mm Hg SBP/DBP) were ... 12-week trial, patients with moderate hypertension (mean baseline 162/98 mm Hg SBP/DBP) ... Hg (P<.01) and 15.7/7.3 mm Hg (P In the severe hypertension study, the incidences of pre-specified adverse ...

UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension

... end-stage kidney disease. Although awareness of hypertension in African Americans has increased in recent ... and professor of medicine and Head, Section of hypertension at the University of Maryland School of Medicine. ... 300 African-American patients with stage I-II hypertension were randomly assigned to receive ...

Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension

... end-stage kidney disease. Although awareness of hypertension in African Americans has increased in recent ... and professor of medicine and Head, Section of hypertension at the University of Maryland School of Medicine. ... 300 African-American patients with stage I-II hypertension were randomly assigned to receive ...

Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension

... therapy for the treatment of pulmonary arterial hypertension (PAH). Data from both studies suggest that ... About Tracleer(R) in Pulmonary Arterial hypertension (PAH) Tracleer(R) (bosentan), the first oral ... and development in the pulmonary arterial hypertension (PAH) disease area. More than 40,000 PAH patients ...

Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in Miami

... tus manos) with the goal of raising awareness of hypertension (high blood pressure), promoting prevention, and ... proportion of the Hispanic population with hypertension who are unaware of their condition and do not ... and Prevention (CDC) found that Hispanics with hypertension are less likely to be aware of their ...

Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics' Hypertension Better Controlled With Equal Access to Care

... rapid access journal report: Hispanics' hypertension better controlled with equal access to care ... Population-based research has shown that hypertension awareness, treatment and control is lower among ... initial drugs, and then additional therapy if the hypertension was not controlled. "The goal was for ...

Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension

... blood pressure in patients with mild-to-moderate hypertension and we anticipate it will be an important therapy for physicians." About hypertension Hypertension, also known as high blood pressure, ... to an acceptable range. If left untreated, hypertension can eventually damage important organs such as ...

Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology

... with Higher Incidence of hypertension in United States SAN DIEGO, Aug. 7 ... new local coverage allows treatment for resistant hypertension (uncontrolled blood pressure on three or more ... The changes in local coverage allowing ICG hypertension coverage occurred after a November 2006 CMS ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... blood pressure reductions, compared to taking either drug alone." hypertension affects nearly 74 million US adults and is a major risk factor for ... efficacy of Tekturna HCT were evaluated in patients with mild-to-moderate hypertension in an 8-week, randomized, double-blind, placebo-controlled, ...

FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

... type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH). ADCIRCA is indicated to improve exercise ability in WHO Group I ... rights to develop, market, promote and commercialize ADCIRCA for pulmonary hypertension in the United States and Puerto Rico from Eli Lilly & Company in ...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... tract infection (6% CIMZIA, 2% placebo), headache (5% CIMZIA, 4% placebo), hypertension (5% CIMZIA, 2% placebo), nasopharyngitis (5% CIMZIA, 1% placebo), back ... occurred more frequently among patients with a baseline history of hypertension and among patients receiving concomitant corticosteroids and non-steroidal ...

Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion

... PROCRIT is contraindicated in patients with uncontrolled hypertension or with known hypersensitivity to albumin (human) or mammalian ... managed, particularly in patients with an underlying history of hypertension or cardiovascular disease. In studies, the most common side ...

Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting

... -- PROCRIT is contraindicated in patients with uncontrolled hypertension or with known hypersensitivity to albumin (human) or mammalian ... managed, particularly in patients with an underlying history of hypertension or cardiovascular disease. -- In studies, the most common side effects ...

Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America

... 2a clinical study with PL-3994 last month in 21 volunteers with controlled hypertension who received the medication or placebo subcutaneously. The results of the ... agents modulating this system may be useful in treatment of heart failure, hypertension and other cardiovascular diseases. Palatin's strategy is to develop ...

Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD

... the potential for a long-acting version of clonidine -- a widely used hypertension drug -- as a safe and effective treatment for ADHD," said Moise ... identified one new drug candidate, a compound code named ADX415, to treat hypertension and other conditions. "With the extremely positive data from our first ...

NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR

... among the four treatment groups for any baseline variables, including hypertension medical history (approximately half of enrolled patients had a medical history of hypertension at baseline). NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a ...

Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration

... from seven presentations concerning the treatment of pulmonary arterial hypertension (PAH) with treprostinil were reported at the American Thoracic Society ... 2008, at 5:00 pm EDT. Vallerie McLaughlin, MD, Director of the Pulmonary hypertension Program at the University of Michigan, will join United Therapeutics' ...

Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension

... drug designation to Terguride for the treatment of pulmonary arterial hypertension (PAH). Terguride is currently being evaluated for PAH in a pivotal Phase ... pituitary. About Pulmonary arterial hypertension Pulmonary arterial hypertension is a disorder of the blood vessels in the lung, in which the pressure in ...

Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings

... medical costs related to chronic kidney disease (CKD) patients with hypertension or diabetes, and show the impact on hemoglobin (Hb) control using ... managed, particularly in patients with an underlying history of hypertension or cardiovascular disease. -- In studies, the most common side effects ...

InterCure Announces 100,000th RESPeRATE Unit Sold

... Ltd. (Tel Aviv Stock Exchange: INCR) manufacturer of the RESPeRATE(R) hypertension treatment device, clinically-proven to significantly lower blood pressure, ... nervous system. InterCure is successfully selling the world's first hypertension treatment device, RESPeRATE(R), with more than 100,000 units sold. With ...

Sarasota's Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimer's Disease Research

... of 15 amnestic mild cognitive impairment (MCI) patients with essential hypertension were divided into two groups. A group of eight participants were randomly ... is one of the top drugs sold in the United States for the treatment of hypertension (high blood pressure), Nilvadipine, is currently not available in the U.S. ...

NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update

... and non-hypertensive patients, although patients with uncontrolled hypertension have been excluded. The two doses of naproxcinod (750 mg and 375 mg bid) ... points. Additional secondary endpoints will assess the appearance of new hypertension or worsening of pre-existing hypertension. NicOx (Bloomberg: COX:FP, ...

Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease

... in the previous 12 months. Specifically, 90 percent of patients with hypertension and CKD, 60 percent of patients with diabetes and CKD, and 52 percent of patients with diabetes, hypertension and CKD did not receive the microalbumin test during this time period. ...
Other Contents
(Date:9/16/2014)... September 13, 2014. The fire is human-caused and ... acres in size and is mostly being fueled by ... Monday night due to higher humidity. Yesterday (8/15), ... to construct a fireline on the West and North sides ... the fire: , 7 20-person Crews, 4 Hot Shot Crews, ...
(Date:9/16/2014)... -- Each tree species has its own bacterial identity. ... colleagues from other institutions who studied the genetic fingerprints ... a Panamanian island. , "This study demonstrates for the ... and with different ecological strategies possess very different microbial ... Kembel, a former postdoctoral researcher in the UO,s Institute ...
(Date:9/16/2014)... new football season and another commercial cargo flight to ... is scheduled to blast off to the orbital laboratory ... fourth contracted mission to the complex. , Included in ... investigations sponsored by the Center for the Advancement of ... the U.S. National Laboratory on the space station, CASIS ...
Breaking Biology News(10 mins):Microbiome research shows each tree species has a unique bacterial identity 2CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3
(Date:9/17/2014)... Asian Americans at higher risk of developing type 2 ... disease at lower body weights? One part of this ... low-fat Asian diets to current westernized diets, which may ... George King, M.D., Senior Vice President and Chief Scientific ... of the study. , A Joslin randomized clinical trial ...
(Date:9/17/2014)... The in vitro diagnostics (IVD) marketplace ... focusing on molecular diagnostics for conditions such as infectious ... The IVD market value is projected to be worth ... The major drivers of the market’s growth include the ... evidenced by the explosion for raid and minimally-invasive diagnostic ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. 17, 2014 ... explain why antibiotic-resistant bacteria can thrive in a hospital setting. ... be the culprit. They can easily enter bacteria and move ... that makes bacteria drug-resistant, a new study finds. "The ... a class of antibiotic called carbapenems," said the study,s co-author, ...
(Date:9/17/2014)... Research has shown that most 18-month-olds learn an average ... little is known about how children process information to ... years. In a new study, a University of Missouri ... they age, and a limit exists as to how ... could help parents enhance their children,s vocabularies and assist ...
(Date:9/17/2014)... September 17, 2014 Celestix Networks, ... solutions, today announced that it will launch a ... 2014. This new offering will provide seamless Active ... Software-as-a-Service applications to enable secure single sign-on and ... of cloud computing, there has been a dramatic ...
Breaking Medicine News(10 mins):Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 2Health News:In Joslin trial, Asian Americans lower insulin resistance on traditional diet 3Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 2Health News:World In Vitro Diagnostics Market Analysed by VPG in In-demand Research Report Available at MarketPublishers.com 3Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 3Health News:Babies learn words differently as they age, researcher finds 2Health News:Celestix Announces Availability of ADFS Bridge Appliance in October 2014 to Simplify the Configuration of Office 365 with Active Directory 2
Other TagsOther Tags